PNPLA3 and metabolic dysfunction-associated steatotic liver disease: This study demonstrated an association between the increased risk of biopsy-confirmed NAFLD and PNPLA3 as well as TM6SF2 variants and a trend towards a lower NAFLD risk in carriers of the HSD17B13 polymorphism.